Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

Completed · Phase 3 · Has a placebo group

Conditions studied: Jet Lag Type Insomnia

In brief

The aim of this study is to investigate tasimelteon vs. placebo on sleep in healthy individuals after a phase advance in jet lag type insomnia.

Key facts

Study ID

NCT03373201

Run by

Vanda Pharmaceuticals

People needed

320

Starts

2017-10-16

Expected to finish

2018-03-05

Last updated by the study team

2023-09-15

Who can join

Age: 18 and older, up to 75. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Ability and acceptance to provide written consent, fluent in English;
• Healthy subjects with no medical, psychiatric or current sleep disorders;
• Men or women between 18-75 years;
• Body Mass Index of ≥ 18 and ≤ 30 kg/m2.

You may not qualify if…

• Major surgery, trauma, illness or immobile for 3 or more days within the past month;
• Pregnancy or recent pregnancy (within 6 weeks);
• A positive test for drugs of abuse at the screening or evaluation visit.

Where it is running

• Vanda Investigational Site — Little Rock, Arkansas, United States
• Vanda Investigational Site — Alameda, California, United States
• Vanda Investigational Site — San Diego, California, United States
• Vanda Investigational Site — Santa Monica, California, United States
• Vanda Investigational Site — Oakland Park, Florida, United States
• Vanda Investigational Site — Atlanta, Georgia, United States
• Vanda Investigational Site — Chevy Chase, Maryland, United States
• Vanda Investigational Site — St Louis, Missouri, United States
• Vanda Investigational Site — New York, New York, United States
• Vanda Investigational Site — Cincinnati, Ohio, United States
• Vanda Investigational Site — Oklahoma City, Oklahoma, United States
• Vanda Investigational Site — Houston, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.